Stay updated on Pembrolizumab Combo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA citation for the Maveropepimut-S, pembrolizumab and low-dose cyclophosphamide paper was added to the Publications section, replacing the previous 'Online ahead of print' entry with the finalized Nat Commun article details (authors, title, journal, date, volume, and DOI).SummaryDifference0.1%

- Check18 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a new page release. This update reflects backend/frontend maintenance and does not modify study details or how the page is used by visitors.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page footer shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a minor interface update.SummaryDifference0.1%

- Check61 days agoChange DetectedThe site revision was updated from v3.6.0 to v3.6.3, indicating a deployment that likely includes fixes or minor improvements without changing the study content.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded a recruitment status note 'No longer looking for participants' and new navigation/help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study', 'Intervention/Treatment'). The revision footer updated from v3.5.5 to v3.6.0 to reflect the site update.SummaryDifference0.4%

- Check82 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a minor update to the page's revision metadata. The change does not modify visible content or functionality.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.